Meirav Kedmi MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Improving the Outcome of High-risk Aggressive B-cell Lymphoma Patients With Nivolumab Maintenance Therapy (NCT03569696) | Meirav Kedmi MD | 2018-10-08 |
Track Meirav Kedmi MD automatically
Every clearance here is in the API, with alerts when new ones post.